AI Image
Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns
Yahoo Health • • health
Key Points:
- Many patients discontinue GLP-1 medications like Ozempic, Wegovy, and Zepbound within a year due to side effects such as nausea and gastrointestinal issues or a preference to avoid long-term medication.
- Stopping GLP-1 drugs often leads to rapid weight regain, increased appetite ("food noise"), and loss of metabolic benefits including cardiovascular protection, with studies showing significant weight regain within a year after cessation.
- Discontinuation can also reverse improvements in blood sugar, cholesterol, fatty liver disease, and may negatively impact muscle mass, potentially worsening long-term physical function and metabolism.
- The mental health impact of stopping GLP-1s can be severe for patients who view these drugs as a final solution after repeated weight-loss challenges, leading to feelings of loss of control and discouragement.
- Successful discontinuation may be possible when metabolic goals are met and sustainable lifestyle changes, particularly in diet, are adopted; patients are advised to work closely with their healthcare providers to develop a safe stopping plan and ongoing monitoring.
